首页> 美国卫生研究院文献>Clinical and Experimental Vaccine Research >A potent multivalent vaccine for modulation of immune system in atherosclerosis: an in silico approach
【2h】

A potent multivalent vaccine for modulation of immune system in atherosclerosis: an in silico approach

机译:一种有效的调节动脉粥样硬化免疫系统的多价疫苗:计算机方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PurposeAtherosclerosis is classically defined as an immune-mediated disease characterized by accumulation of low-density lipoprotein cholesterol over intima in medium sized and large arteries. Recent studies have demonstrated that both innate and adaptive immune responses are involved in atherosclerosis. In addition, experimental and human models have recognized many autoantigens in pathophysiology of this disease. Oxidized low-density lipoproteins, β2 glycoprotein I (β-2-GPI), and heat shock protein 60 (HSP60) are the best studied of them which can represent promising approach to design worthwhile vaccines for modulation of atherosclerosis.
机译:目的动脉粥样硬化通常定义为一种免疫介导的疾病,其特征是低密度脂蛋白胆固醇在中型和大型动脉内膜上积累。最近的研究表明,先天性和适应性免疫反应均与动脉粥样硬化有关。另外,实验模型和人体模型已经在该疾病的病理生理学中认识到许多自身抗原。氧化的低密度脂蛋白,β2糖蛋白I(β-2-GPI)和热休克蛋白60(HSP60)是研究得最好的,可以代表设计有希望的调节动脉粥样硬化疫苗的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号